跳至主要内容
临床试验/IRCT2017022232719N1
IRCT2017022232719N1已完成未知

The effect of Curcumin on serum lipid profiles and systemic inflammation in hemodialysis patients

Vice chancellor for research,Sabzevar University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 75 years(—)
性别
All

入选标准

  • I The patient's tendency to participating in study and signing approval form? Having a history of at least 6 months of dialysis? age between 25-75 years old ? BMI between 18.5 to 30? Lack of infectious disease, particularly hepatitis? Avoiding the use of no steroidal anti-inflammatory drugs, Nicotinic Acid, estrogen, progesterone and Curcumin supplementation for at least one month before the start of the study? Lack of drug addiction? Lack of severe heart disease, liver failure and thyroid, severe gastrointestinal bleeding and peptic ulcer disease, cholelithiasis, pregnancy or lactation Exclusion criteria: Increasing of potassium in patients' blood during the study? unwilling to continue to participate?Death of the patient? Performing kidney transplantation? Increasing in dose of anti-fat drugs? Changing patient's lifestyle or diet during the study? The use of herbal medicines for lipid lowering during the study? No adherence to study intervention of at least 9 tablets during two months of interference

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research,Sabzevar University of Medical Sciences

相似试验

The effect of Curcumin on serum lipid profiles and... | 临床试验